Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population

During spring 2021, AZD1222 and BNT162b2 were used as prime and BNT162b2 as booster COVID-19 vaccines in Denmark. We obtained self-reported information on systemic reactogenicity day-by-day during two weeks for 2862 healthcare workers vaccinated with heterologous AZD1222 + BNT162b2 or homologous BNT...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabatabaeifar, Sorosh, Vestergaard, Jesper M., Würtz, Else T., Hansen, Karoline K., Nielsen, Kent J., Schlünssen, Vivi, Kolstad, Henrik A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Short communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010832/
https://www.ncbi.nlm.nih.gov/pubmed/36945661
http://dx.doi.org/10.1016/j.jvacx.2023.100280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010832/
https://www.ncbi.nlm.nih.gov/pubmed/36945661
http://dx.doi.org/10.1016/j.jvacx.2023.100280

Ejemplares similares